BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23126475)

  • 21. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.
    García-Campayo J; Serrano-Blanco A; Rodero B; Magallón R; Alda M; Andrés E; Luciano JV; del Hoyo YL
    Trials; 2009 Apr; 10():24. PubMed ID: 19389246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with fibromyalgia newly prescribed pregabalin or tricyclic antidepressants.
    Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
    J Med Econ; 2012; 15(1):32-44. PubMed ID: 21970698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging therapies for fibromyalgia: an update.
    Ablin JN; Buskila D
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):521-33. PubMed ID: 20486862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
    Sun P; Zhao Y; Zhao Z; Watson P
    Curr Med Res Opin; 2011 Sep; 27(9):1793-801. PubMed ID: 21810060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical treatment options for fibromyalgia.
    Crofford LJ
    Curr Rheumatol Rep; 2004 Aug; 6(4):274-80. PubMed ID: 15251075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical conditions in fibromyalgia patients and their relationship to pregabalin efficacy: pooled analysis of Phase III clinical trials.
    Bhadra P; Petersel D
    Expert Opin Pharmacother; 2010 Dec; 11(17):2805-12. PubMed ID: 21039311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin.
    Gore M; Sadosky AB; Zlateva G; Clauw DJ
    Pain Pract; 2009; 9(5):363-74. PubMed ID: 19500273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duloxetine: an emerging evidence for fibromyalgia.
    Pae CU; Marks DC; Han C; Patkar AA; Masand PS
    Biomed Pharmacother; 2009 Jan; 63(1):69-71. PubMed ID: 18502090
    [No Abstract]   [Full Text] [Related]  

  • 29. Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia.
    Gore M; Sadosky A; Zlateva G; Clauw D
    Am J Manag Care; 2010 May; 16(5 Suppl):S144-53. PubMed ID: 20586523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of duloxetine in fibromyalgia.
    Ursini F; Pipicelli G; Grembiale RD
    Clin Ter; 2010; 161(4):391-5. PubMed ID: 20931165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
    Sommer C; Häuser W; Alten R; Petzke F; Späth M; Tölle T; Uçeyler N; Winkelmann A; Winter E; Bär KJ;
    Schmerz; 2012 Jun; 26(3):297-310. PubMed ID: 22760463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibromyalgia and sleep.
    Spaeth M; Rizzi M; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2011 Apr; 25(2):227-39. PubMed ID: 22094198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG; Pritchett YL; Desaiah D; Raskin J
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregabalin: a treatment for fibromyalgia and other painful conditions.
    Smith SM
    Nurs Womens Health; 2008 Oct; 12(5):432-5. PubMed ID: 18837723
    [No Abstract]   [Full Text] [Related]  

  • 35. A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions.
    Roth T; Arnold LM; Garcia-Borreguero D; Resnick M; Clair AG
    Sleep Med Rev; 2014 Jun; 18(3):261-71. PubMed ID: 24119681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
    Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E
    Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
    Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibromyalgia syndrome: a relevant recent construction of an ancient condition?
    Perrot S
    Curr Opin Support Palliat Care; 2008 Jun; 2(2):122-7. PubMed ID: 18685409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibromyalgia coverage uneven despite recent drug approvals.
    Sipkoff M
    Manag Care; 2008 Dec; 17(12):9-10. PubMed ID: 19127758
    [No Abstract]   [Full Text] [Related]  

  • 40. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
    Caro XJ; Winter EF; Dumas AJ
    Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.